Search results for "biopharma 4.0"

Article eBook: Purification of Antibody Therapeutics - Approach for Diversified Pipeline
Antibody therapeutics are the largest class of biotherapeutics. Over the years, development beyond traditional monoclonal antibodies (mAbs) has increased. Today, we see multispecific and bispe…

Article Expanding the Emerging Therapeutic Horizon
Despite the successes that have already been achieved with emerging therapy development and manufacturing, companies are still facing numerous challenges. Aspects such as demand for accelerate…

Article How to program, run and evaluate a design of experiments (DoE)
In this free, interactive course, Dr. Martin Sichting, Product Manager Lab Scale Chromatography Systems at Cytiva, guides you through the DoE process. You’ll learn how to program, run, and e…

Article What is process development?
What is process development? Biopharma process development comprises the activities that help you create a series of steps to produce a biomolecule – a monoclonal antibody (mAb), recomb…

Article Report from the 12th Plasma Product Biotechnology Forum
Since the first meeting in 1999, the PPB forum has established itself as the key international forum for the plasma manufacturing industry – read our report for the highlights of the 2022 conference…

Article Recent Trends in Data Analytics for Upstream Process Workflows
Modeling techniques can improve process control and monitoring in biopharmaceutical production. Read more about it here >>

Article Top Process Development Trends for 2021 and a Look into 2022
The COVID-19 pandemic continues to shape bioprocess development trends, and many lessons have been learned from industry’s response to and preparedness for dealing with a public health crisis. Howev…

Article Pandemic Alters Policies and Practices for Drug Development and Regulation
By Jill Wechsler The need for medicines to combat COVID-19 has impacted the way regulatory agencies carry out their operations. Drug development and regulati…

Article Improving Productivity During Process Development and Scaling of Your Process
PD Click here to view more Industry Leader Q&As >> Andreas Castan, PhD, Strategic Technology Partnerships Leader of Business Development & Strategy at Cytiva, provides helpful insig…

Article mRNA Vaccines: Current Trends and Perspectives
Read more >> mRNA therapy is a rapidly growing field. The technology offers great benefit and potential for infectious diseases and personalized medicines due to its advantages in flexibility, co…

Previous PageNext Page